New anesthesia drug could make surgery safer for seniors

NCT ID NCT06690424

Completed Symptom relief Sponsor: Affiliated Hospital of Nantong University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares remimazolam, a newer sedative, to the standard drug propofol for anesthesia in 92 elderly patients (ages 60-75) undergoing thyroid surgery. The goal is to see if remimazolam provides smoother induction, stable vital signs, and faster recovery with fewer complications like confusion or irregular heartbeat. Results could lead to a safer anesthesia choice for older adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remimazolam
What this could lead to: If successful, remimazolam could offer a safer anesthesia option for elderly patients, with fewer side effects like low blood pressure or confusion after surgery.
What could go wrong: This is a small, single-center trial with only 92 participants, so results may not apply to all elderly patients. Remimazolam may not prove better than propofol in larger studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EFFICACY AND SAFETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thyroid tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EFFICACY AND SAFETY

Contacts and locations

Locations

Affiliated Hospital of Affiliated Hospital

Nantong, Jiangsu, 226001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.